Company profilePharmaceutical#626 of 1,318 in Pakistan1 DRAP alert

LAWRENCE PHARMA

Pharmaceutical company · 17 brands · 27 molecules

Ranked #102 of 146 companies in Antiemetics & Antinauseants

17 registered products 12 pharmaceutical brands 27 distinct molecules 1 DRAP alert

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

LAWRENCE PHARMA is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 17 product registrations across 27 distinct molecules. Its portfolio is concentrated in Antiemetics & Antinauseants and Vitamin B12 Plain. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Dipyrone2 brands

Dimenhydrinate1 brand

Ranitidine1 brand

Diclofenac1 brand

Quinine1 brand

Mecobalamin1 brand

Vitamin B121 brand

Phytomenadione1 brand

Pheniramine1 brand

Triamcinolone1 brand

Therapeutic classes

Price band (DRAP official ceilings)

Registered products priced by source

DRAP-official5 products · Rs 18.28 – Rs 1,959.2

Median across source: Rs 127.55

Regulatory record

1 alert in the DRAP feed we track.

Rapid Alert; Drug Product: Falsified Phenobar 30mg Tablets identified in the Market

2023-06-07

Competitive set

Companies whose registered portfolio overlaps most with this one.

HARMANN PHARMACEUTICAL LABORATORIES (PVT) LTD.11 shared molecules

VENUS PHARMA10 shared molecules

MEDICRAFT PHARMACEUTICALS (PVT) LTD.9 shared molecules

NEUTRO PHARMA (PVT) LTD.9 shared molecules

Wilshire Laboratories (Private) Limited8 shared molecules

DANAS PHARMACEUTICALS (PVT) LTD7 shared molecules

FRIENDS PHARMA (PVT) LTD7 shared molecules

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD.7 shared molecules

MEDIATE PHARMACEUTICALS (PVT) LTD7 shared molecules

BLOOM PHARMACEUTICALS (PVT) LTD.7 shared molecules

Get the full profile for LAWRENCE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included